TG Therapeutics, Inc. (TGTX)
31.58
+0.64
(+2.08%)
USD |
NASDAQ |
Jan 21, 16:00
31.58
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Market Cap: 5.014B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.431B |
| MannKind Corp. | 1.756B |
| Karyopharm Therapeutics, Inc. | 107.93M |
| Axsome Therapeutics, Inc. | 9.531B |
| Krystal Biotech, Inc. | 8.293B |
Market Cap Related Metrics
| PE Ratio | 11.37 |
| PS Ratio | 9.599 |
| Price to Book Value | 8.258 |
| Price | 31.58 |
| Earnings Yield | 8.80% |
| Operating PE Ratio | 49.67 |
| Normalized PE Ratio | 11.36 |